Tuesday, October 28, 2008

Dog asthma treatment

Article source Link, Article source Link,


Morris said that such initiatives have taken place at other universities. Specifically, she points to the work of the University of Pennsylvania's Netter Center for Community Partnerships that has helped develop an extensive list of what it calls 'Academically Based Community Service' courses offered each semester to both undergraduate and graduate students. In one course, Penn students collaborate with the Children's Hospital of Philadelphia on a clinical research study titled the Community Asthma Prevention Program. The Penn undergraduates learn about the epidemiology of urban asthma in the classroom and then go out to co-teach asthma classes offered at community centers throughout the city. In another Netter Center course, called the Community Algebra Initiative, Penn students conduct hands-on activities with students at a local high school.
Morris said that the Netter Center offers more than 20 such service-learning courses each year.
'Down the line, I see Johns Hopkins developing a similar list of for-credit courses offered through the various schools within the university,' she said



About Quintiles
Quintiles Transnational Corp. fuels the new generation of medical care byproviding a broad range of professional services in drug development,financial partnership, and marketing for the pharmaceuticals, biotechnology,and medical care industries. With over 21,000 employees, and offices in over50 countries, it is focused on providing customer-centered solutions thatconstitute the reference standard for the industry.
For further information, please consult the Web Site of the Company atwww.quintiles.com.
About Stallergenes
Stallergenes is a European biopharmaceutical company dedicated todesensitization therapies for the prevention and treatment of allergy-relatedrespiratory diseases, e.g. rhinoconjunctivitis and allergic asthma. A pioneerand leader in sublingual desensitization treatments, Stallergenes devotes 20%of its turnover in raw data to Research and Development and is activelyinvolved in the development of a new therapeutic class: sublingualdesensitization tablets.
In 2007, Stallergenes had a turnover of 147 million euros and provideddesensitization treatments to more than 500,000 patients.
Stallergenes is listed on Euronext Paris (Compartment B) and is part ofthe sample composing the SBF 120 index



Blog Archives:
Allergic asthma symptoms

Moped exhaust

49cc mopeds

Rubber flooring tile

Glass tile wholesale

T shirts printed

Moped comparison

Granite tile prices

Shirts blouses

Garage tool cabinet

Asthma resources

Polo shirts cheap

Hardware kitchen cabinets

Yamaha razz moped

Izod golf shirt

Airbrush t shirt

Suzuki mopeds